Tectonic Therapeutic (TECX) Current Deferred Revenue (2019 - 2022)
Tectonic Therapeutic (TECX) reported Current Deferred Revenue of $51000.0 for Q3 2022, down 80.83% year-over-year from $266000.0 in Q3 2021, and down 72.13% quarter-over-quarter from $183000.0 in Q2 2022.
Tectonic Therapeutic (TECX) Current Deferred Revenue (2019 - 2022) Analysis & Trends
Tectonic Therapeutic (TECX) has 4 years of Current Deferred Revenue data on file, last reported at $51000.0 in Q3 2022.
- Current Deferred Revenue for Q3 2022 came in at $51000.0, down 80.83% year-over-year; the trailing twelve-month figure through Sep 2022 was $51000.0 (down 80.83% YoY), and the FY2021 annual result was $262000.0, up 9.62% from the prior year.
- Current Deferred Revenue fell to $51000.0 in Q3 2022 per TECX's latest filing, from $183000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $266000.0 in Q3 2021 and troughed at $51000.0 in Q3 2022.
- A 4-year average of $215200.0 and a median of $227500.0 in 2020 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2021 and 2022: Current Deferred Revenue grew 23.15% in 2021, then plunged 80.83% in 2022.
- A 4-year view of Current Deferred Revenue shows it stood at $214000.0 in 2019, then grew by 11.68% to $239000.0 in 2020, then climbed by 9.62% to $262000.0 in 2021, then plunged by 80.53% to $51000.0 in 2022.
- Business Quant data shows TECX's Current Deferred Revenue at $51000.0 in Q3 2022, $183000.0 in Q2 2022, and $214000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 51,000.00 |
| Jun 30, 2022 | 183,000.00 |
| Mar 31, 2022 | 214,000.00 |
| Dec 31, 2021 | 262,000.00 |
| Sep 30, 2021 | 266,000.00 |
| Jun 30, 2021 | 259,000.00 |
| Mar 31, 2021 | 248,000.00 |
| Dec 31, 2020 | 239,000.00 |
| Sep 30, 2020 | 216,000.00 |
| Dec 31, 2019 | 214,000.00 |